Selective blockade of AT1 angiotensin II receptors abolishes ischemic preconditioning in isolated rabbit hearts

Journal of Molecular and Cellular Cardiology

Volumn 29, Issue 1, 1997, Pages 129-139

  Diaz, Roberto J ^a   Wilson, Gregory J ^a,b  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Angiotensin II; AT1 receptors; AT2 receptors; Ischemia; Myocardial infarction; Preconditioning; Rabbit; Reperfusion

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR; LOSARTAN; RECEPTOR SUBTYPE; SARALASIN; ANGIOTENSIN RECEPTOR; BIPHENYL DERIVATIVE; IMIDAZOLE DERIVATIVE; TETRAZOLE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; CONDITIONING; CONTROLLED STUDY; FEMALE; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART VENTRICLE FUNCTION; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RECEPTOR BLOCKING; ANALYSIS OF VARIANCE; ANIMAL; COMPARATIVE STUDY; CORONARY ARTERY BLOOD FLOW; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART LEFT VENTRICLE FUNCTION; IN VITRO STUDY; PATHOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANALYSIS OF VARIANCE; ANIMALS; BIPHENYL COMPOUNDS; CORONARY CIRCULATION; DRUG EVALUATION, PRECLINICAL; FEMALE; IMIDAZOLES; ISCHEMIC PRECONDITIONING, MYOCARDIAL; LOSARTAN; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; RABBITS; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM; SARALASIN; TETRAZOLES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0030614664     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0258     Document Type: Article

References (36)

1. BANERJEE A, LOCKE-WINTER C, ROGERS KB, MITCHELL MB, BREW EC, CAIRNS CB, BENSARD DD, HERKEN AH, 1993. Preconditioning against myocardial dysfunction after ischemia reperfusion by an α1-adrenergic mechanism. Circ Res 73: 656-670.
2. BERNE RM, RUBIO R, 1974. Adenine nucleotide metabolism in the heart. Circ Res 35 (suppl 3): 109-120.
3. BREW EC, MITCHELL MB, REHRING TF, GAMBONI-ROBERTSON F, MCINTYRE RC JR, HARKEN AH, BANERJEE A, 1995. Role of bradykinin in cadiac functional protection after global ischemia-reperfusion in rat heart. Am J Physiol 269: H1370-H1378.
4. BRINK M, DE GASPARO M, ROGG H, WHITEBREAD S, BULLOCK G, 1995. Localization of angiotensin II receptor sub-types in the rabbit heart. J Mol Cell Cardiol 27: 459-470.
5. DE LANNOY LM, JAN DANSER AH, BOUHUIZEN AMB, SCHOEMAKER RG, SAXENA PR, SCHALEKAMP ADH, 1995. Angiotensin generation in cardiac interstitial fluid (Abstract). Circulation 92: I-28.
6. ERTL G, SLEXANDER RW, KLONER RA, 1983. Interactions between coronary occlusion and renin-angiotensin system in the dog. Basic Res Cardiol 78: 518-533.
7. GONDO M, MARUTA H, ARAKAWA K, 1989. Direct formation of angiotensin II without renin or converting enzyme in the ischemic dog heart. Jpn Heart J 30: 219-229.
8. GOTO M, LIU Y, YANG XM, ARDELL JL, COHEN MV, DOWNEY JM, 1995. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 77: 611-621.
9. IKONOMIDIS JS, TUMIATI LC, WEISEL RD, MICKEL DA, LI RK, 1994. Preconditioning human ventricular cardiomyocytes with brief periods of simulated ischaemia. Cardiovasc Res 28: 1285-1291.
10. KIDA M, FUJIWARA H, ISHIDA M, KAWAI C, OHURA M, MIURA I, YABUUCHI Y, 1991. Ischemic preconditioning preserves creatine phosphate and intracellular pH. Circulation 84: 2495-2503.
11. KITAKAZE M, HORI M, MORIOKA T, MINAMINO T, TAKASHIMA S, SATO H, SHINOZAKI Y, CHUJO M, MORI H, INOUE M, 1994. Alpha 1-adrenoceptor activation mediates the infarct size-limiting effect of ischemic preconditioning through augmentation of 5'-nucleotidase activity. J Clin Invest 93: 2197-2205.
12. LANG U, VALLOTTON MB, 1989. Effects of angiotensin II and of phorbol ester on protein kinase C activity and on prostacyclin production in culture rat aortic smooth-muscle cells. Biochem J 259: 477-483.
13. LINDPAINTNER K, GANTEN D, 1994. The Cadiac Renin-Angiotensin System. New York, Futura Publishing Company, Inc.
14. LINDPAINTNER K, JIN MW, NEIDERMEIER N, WILHELM MJ, GANTEN D, 1990. Cardiac angiotensinogen and its local activation in the isolated perfused beating heart. Circ Res 67: 654-573.
15. LIU Y, DOWNEY JM, 1992. Ischaemic preconditioning protects against infarction in the rat heart. Am J Physiol 263: H1107-H1112.
16. LIU GS, THORNTON J, VAN WINKLE DM, STANLEY AWH, OLSSON RA, DOWNEY JM, 1991. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 84: 350-356.
17. LIU Y, TSUCHIDA A, COHEN MV, DOWNEY JM, 1994a. Pretreatment with angiotensin II activates protein kinase C and limits infarction in isolated rabbit hearts. J Mol Cell Cardiol 27: 883-892.
18. LIU Y, YTREHUS K, DOWNEY JM, 1994b. Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. J Mol Cell Cardiol 26: 661-668.
19. LIU Y, CORDIS GA, DAS DK, DOWNEY JM, COHEN MV, 1995. Protein kinase C may be activated by phospholipase D rather than C in ischemic preconditioning (Abstract). J Mol Cell Cardiol 27: A-41.
20. MATSUKI T, SHOJI T, YOSHIDA S, KUDOH Y, MOTOE M, INOUE M, NAKATA T, HOSODA S, SHIMAMOTO K, YELLON D, IIMURA O, 1987. Sympathetically induced myocardial ischaemia causes the heart to release plasma kinin. Cardiovasc Res 21: 428-432.
21. MURRY CE, JENNINGS RB, REIMER KA, 1986. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136.
22. NODA K, SASAGURI M, IDEISHI M, IKEDA M, ARAKAWA K, 1993. Role of locally formed angiotensin II and bradykinin in the reduction of myocardial infarct size in dogs. Cardiovasc Res 27: 334-340.
23. OKUNISHI H, MIYASAKI M, TODA N, 1984. Evidence for a putatively new angiotensin II-generating enzyme in the vascular wall. J Hypertens 2: 277-284.
24. PORSTI I, HECKER M, BASSENGE E, BUSSE R, 1993. Dual action of angiotensin II on coronary resistance in the isolated perfused rabbit heart. Naunym-Schmiedebergs Arch Pharmacol 348: 650-658.
25. ROGG H, SCHMID A, DE GASPARO M, 1990. Identification and characterization of angiotensin II receptor subtypes in rabbit ventricular myocardium. Biophys Biochem Res Commun 173: 416-422.
26. RUZICKA M, SKARDA V, YUAN B, ROSENTHAL J, LEENEN FHH, 1995. Changes in plasma and cardiac angiotensin II in response to acute myocardial infarction in rats (Abstract). Circulation 92: I-454.
27. SANDHU R, DIAZ RJ, WILSON GJ, 1993. Comparison of ischemic preconditioning in blood perfused and buffer perfused isolated heart models. Cardiovasc Res 27: 602-607.
28. SANDHU R, THOMAS U, DIAZ RJ, WILSON GJ, 1996. Effect of ischemic preconditioning of the myocardium on cyclic AMP. Circ Res 78: 137-147.
29. SCHOTT RJ, ROHMANN S, BRAUN ER, SCHAPER W, 1990. Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res 66: 1113-1142.
30. SHÖMIG A, 1990. Catecholamines in myocardial ischemia: systemic and cardiac release. Circulation 82 (Suppl 3): II-13-II-22.
31. SIEMENS IR, REAGAN LP, YEE DK, FLUHARTY SJ, 1994. Biochemical characterization of two distinct angiotensin AT2 receptor populations in murine neuroblastoma N1E-115 cells. J Neurochem 62: 2106-2115.
32. THORNTON JD, LUI GS, OLSSON RA, DOWNEY JM, 1992. Intravenous pretreatment with A1-selective adenosine analogues protects the heart against infarction. Circulation 85: 659-665.
33. THORNTON JD, LIU GS, DOWNEY JM, 1993. Pretreatment with pertussis toxin blocks the protective effects of preconditioning: evidence for a G-protein mechanism. J Mol Cell Cardiol 25: 311-320.
34. TSUCHIDA A, LIU Y, GUANG SL, COHEN MV, DOWNEY JM, 1994. α1-Adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circ Res 75: 576-585.
35. URATA H, KINOSHITA A, MISONO KS, BUMPUS FM, HUSAIN A, 1990. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem 265: 22348-22357.
36. URATA H, BOEHM KD, PHILLIP A, KINOSHITA A, GABROVSEK J, BUMPUS FM, HUSAIN A, 1993. Cellular localization and regional distribution of a major angiotensin II-forming chymase in the heart. J Clin Invest 91: 1269-1281.